[Metabolic radiotherapy: what role will it have in 2001?].

Author: DouardM C, GeorgeB, RainJ D

Paper Details 
Original Abstract of the Article :
Metabolic radiotherapy is a new therapy for management of bone pain in patients with bone metastatic prostate carcinoma. Strontium-89 and Samarium-153 concentrate in bone metastases and radiate them. A pain decrease is obtained in 60-70% of cases. Side effects are a significant hematological depress...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s1278-3218(02)00161-0

データ提供:米国国立医学図書館(NLM)

A New Frontier in Cancer Treatment: Metabolic Radiotherapy

Bone pain is a distressing symptom associated with bone metastases, a common complication of prostate cancer. This study explores the potential of metabolic radiotherapy, a novel approach using radionuclides, in managing bone pain in patients with bone metastatic prostate carcinoma.

Metabolic Radiotherapy: A Promising Alternative

The study found that metabolic radiotherapy, using strontium-89 and samarium-153, was effective in reducing bone pain in a significant proportion of patients. The researchers highlight the importance of careful patient selection and monitoring of hematological side effects.

Expanding the Treatment Options for Prostate Cancer

This research suggests that metabolic radiotherapy could be a valuable addition to the treatment options for prostate cancer. It offers a potentially effective and less invasive alternative to traditional therapies for managing bone pain associated with bone metastases.

Dr.Camel's Conclusion

The fight against cancer is a constant quest for innovative treatments. This study highlights the potential of metabolic radiotherapy to alleviate a common and debilitating symptom. It's like finding a hidden oasis in a desert of pain, offering a source of relief and hope for patients battling this devastating disease.
Date :
  1. Date Completed 2002-08-12
  2. Date Revised 2019-11-06
Further Info :

Pubmed ID

12116845

DOI: Digital Object Identifier

10.1016/s1278-3218(02)00161-0

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.